Stoked Bio is a translational biotechnology company established to develop new candidates for resistant infectious diseases and cancers identified using a unique, biology-driven ai-assisted drug discovery and optimization platform created and implemented in the Stokes Lab at McMaster University. Stoked Bio’s pipeline will consist of structurally and functionally novel, clinically relevant, easily synthesizable small molecules with validated therapeutic and toxicity profiles that overcome current resistance. Stoked will be responsible for the development of these validated candidates through the preclinical process with the goal of bringing several new therapeutics to IND, ready for first in human trials.